Print Page | Close Window

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

May 23, 2018 - 4:02 p.m.
Gilead Sciences to Present at the Jefferies 2018 Healthcare Conference on Wednesday, June 6Printer Friendly Version 
May 15, 2018 - 10:58 a.m.
U.S. Food and Drug Administration Approves Expanded Indication for Truvada® (Emtricitabine and Tenofovir Disoproxil Fumarate) for Reducing the Risk of Acquiring HIV-1 in AdolescentsPrinter Friendly Version 

Upcoming Events

Wednesday, June 6, 2018 10:30 a.m. ET
Gilead Sciences at Jefferies 2018 Global Healthcare Conference

Most Viewed Links

Updated 05/19/18
1.SEC Filings
2.Annual Reports
4.Fundamentals - Snapshot
5.Stock Information
* Data collected 05/11/18 - 05/18/18

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.